Acute Bronchitis Caused by Bordetella Pertussis Possibly Co-Infected with Mycoplasma Pneumoniae

Itsuro Kazama1,2,3, Toshiyuki Nakajima2

  • 1Miyagi University, School of Nursing, Gakuen, Taiwa, Miyagi, Japan.

Insights

Co-infection with Mycoplasma pneumoniae and Bordetella pertussis can cause severe acute bronchitis. Clarithromycin effectively treated a case by modulating the immune response, unlike garenoxacin.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Respiratory Medicine

Background:

  • Mycoplasma pneumoniae and Bordetella pertussis are common causes of acute bronchitis.
  • Co-infections with these pathogens can lead to prolonged symptoms and severe respiratory complications.

Observation:

  • A 49-year-old unvaccinated female presented with persistent, severe cough, dyspnea, and vomiting.
  • Diagnostic tests revealed positive IgM for Mycoplasma pneumoniae and elevated IgG for Bordetella pertussis.
  • Chest X-ray showed no signs of pneumonia.

Findings:

  • The patient was diagnosed with acute bronchitis due to Bordetella pertussis, with a possible Mycoplasma pneumoniae co-infection.
  • Initial treatment with garenoxacin was ineffective.
  • Administration of clarithromycin resulted in rapid symptom improvement.

Implications:

  • The pathogenesis may involve an exaggerated immune response due to the lymphocyte-stimulatory nature of both pathogens.
  • Clarithromycin's immunosuppressive effect likely reduced lymphocyte activity, leading to disease remission.
  • This case highlights the potential benefit of macrolide antibiotics in managing severe bronchitis co-infections.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
882
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
812
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
855
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
4.2K